Group 1: Company Overview - Ying'en Biopharmaceuticals - Ying'en Biopharmaceuticals (stock code: 09606.HK) officially listed on the Hong Kong Stock Exchange on April 15, raising approximately HKD 1.513 billion through the global offering of 9.7965 million shares, marking a new high for 18A biotech listings since 2022 [1] - The company is a clinical-stage innovative biopharmaceutical firm focused on developing next-generation antibody-drug conjugates (ADCs) for cancer and autoimmune disease patients [1] - Ying'en has established multiple globally patented ADC technology platforms and has a rich clinical ADC development pipeline, conducting multiple global multi-center clinical trials in over 17 countries with more than 2,000 patients enrolled [1] Group 2: Company Strategy and Market Position - Ying'en Biopharmaceuticals - The funds raised from the listing will primarily be used for capacity expansion, research and development activities, and working capital, enabling the company to accelerate product commercialization and enhance innovation capabilities [1] - Ying'en aims to leverage its technological, product, and market advantages to become a leader in driving industry transformation and creating more value for global patients in the booming ADC drug market [1] Group 3: Company Overview - Zhengli New Energy Battery Technology - Zhengli New Energy Battery Technology (stock code: 03677.HK) officially listed on the Hong Kong Stock Exchange on April 14, raising HKD 1.005 billion through its initial public offering [2] - Founded in 2019, the company focuses on the research, production, and sales of power battery products, energy storage batteries, and aviation batteries, providing integrated solutions including cells, modules, battery packs, battery clusters, and battery management systems [2] - Zhengli New Energy has provided high-quality power battery products for global mobility customers across various scenarios, with a cumulative installation scale of nearly 4 million units, making it one of the youngest companies in the top ten of domestic power battery installations [2]
正力新能、映恩生物赴港上市 苏州再添两家上市公司